THE INTESTINAL MICROBIOME IN PATIENTS UNDERGOING BARIATRIC SURGERY: A SYSTEMATIC REVIEW

João Kleber Almeida Gentile, Karen Danielle Oliveira, Júlia Guimarães Pereira, Daniel Yuji Tanaka, Giovanna Nagatsuka Guidini, Melissa Zanetti Cadona, Diego Werneck Siriani-Ribeiro, Mariana Tafner Perondini, João Kleber Almeida Gentile, Karen Danielle Oliveira, Júlia Guimarães Pereira, Daniel Yuji Tanaka, Giovanna Nagatsuka Guidini, Melissa Zanetti Cadona, Diego Werneck Siriani-Ribeiro, Mariana Tafner Perondini

Abstract

Background: Dysbiosis of the gut microbiota is frequently found in cases of obesity and related metabolic diseases, such as type 2 diabetes mellitus. The composition of the microbiota in diabetics is similar to that of obese people, thereby causing increased energy uptake efficiency in the large intestine of obese people, maintenance of a systemic inflammatory state, and increased insulin resistance. Bariatric surgery seems to entail an improvement in gut dysbiosis, leading to an increased diversity of the gut microbiota.

Aims: This study aimed to present a literature review on obesity-associated gut dysbiosis and its status post-bariatric surgery.

Methods: A systematic review of primary studies was conducted in PubMed, SciELO, BIREME, LILACS, Embase, ScienceDirect, and Scopus databases using DeCS (Health Science Descriptors) with the terms "obesity," "intestinal dysbiosis," "bariatric surgery," and "microbiota."

Results: We analyzed 28 articles that had clinical studies or literature reviews as their main characteristics, of which 82% (n=23) corresponded to retrospective studies. The sample size of the studies ranged from 9 to 257 participants and/or fecal samples. The epidemiological profile showed a higher prevalence of obesity in females, ranging from 24.4 to 35.1%, with a mean age of around 25-40 years. There was a variation regarding the type of bariatric surgery, migrating between the Roux-en-Y bypass, adjustable gastric banding, and vertical gastrectomy. Of the 28 studies, 6 of them evaluated the gut microbiota of obese patients undergoing bariatric surgery and their relationship with type 2 diabetes mellitus/glucose metabolism/insulin resistance.

Conclusions: The intestinal microbiota is an important influencer in the regulation of the digestive tract, and obese individuals with comorbidities (diabetes mellitus, hypercholesterolemia, and metabolic syndrome) present important alterations, with an unbalance normal state, generating dysbiosis and the proliferation of bacterial species that favor the appearance of new diseases. Patients who undergo bariatric surgery present an improvement in the intestinal microbiota imbalance as well as reversibility of their comorbidities, increasing their life expectancy.

Conflict of interest statement

Conflicts of interest: None

Figures

Figure 1. Flowchart of the included articles.
Figure 1. Flowchart of the included articles.

References

    1. Abenavoli L, Scarpellini E, Colica C, Boccuto L, Salehi B, Sharifi-Rad J, et al. Gut microbiota and obesity: a role for probiotics. Nutrients. 2019;11(11):2690–2690. doi: 10.3390/nu11112690.
    1. Andrew CA, Umashanker D, Aronne LJ, Shukla AP. Intestinal and gastric origins for diabetes resolution after bariatric surgery. Curr Obes Rep. 2018;7(2):139–146. doi: 10.1007/s13679-018-0302-2.
    1. Aron-Wisnewsky J, Doré J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9(10):590–598. doi: 10.1038/nrgastro.2012.161.
    1. Aron-Wisnewsky J, Prifti E, Belda E, Ichou F, Kayser BD, Dao MC, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2019;68(1):70–82. doi: 10.1136/gutjnl-2018-316103.
    1. Cani PD. Severe obesity and gut microbiota: does bariatric surgery really reset the system? Gut. 2019;68(1):5–6. doi: 10.1136/gutjnl-2018-316815.
    1. Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA. Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications. Adv Nutr. 2019;10(suppl_1):S17–S30. doi: 10.1093/advances/nmy078.
    1. Debédat J, Amouyal C, Aron-Wisnewsky J, Clément K. Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome? Semin Immunopathol. 2019;41(4):461–475. doi: 10.1007/s00281-019-00738-3.
    1. Debédat J, Clément K, Aron-Wisnewsky J. Gut microbiota dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep. 2019;8(3):229–242. doi: 10.1007/s13679-019-00351-3.
    1. Enaud R, Cambos S, Viaud E, Guichoux E, Chancerel E, Marighetto A, et al. Gut microbiota and mycobiota evolution is linked to memory improvement after bariatric surgery in obese patients: a pilot study. Nutrients. 2021;13(11):4061–4061. doi: 10.3390/nu13114061.
    1. Juárez-Fernández M, Román-Sagüillo S, Porras D, García-Mediavilla MV, Linares P, et al. Long-term effects of bariatric surgery on gut microbiota composition and faecal metabolome related to obesity remission. Nutrients. 2021;13(8):2519–2519. doi: 10.3390/nu13082519.
    1. Kim YJ, Womble JT, Gunsch CK, Ingram JL. The gut/lung microbiome axis in obesity, asthma, and bariatric surgery: a literature review. Obesity (Silver Spring) 2021;29(4):636–644. doi: 10.1002/oby.23107.
    1. Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance. Ann N Y Acad Sci. 2020;1461(1):37–52. doi: 10.1111/nyas.14107.
    1. Leung R, Covasa M. Do gut microbes taste? Nutrients. 2021;13(8):2581–2581. doi: 10.3390/nu13082581.
    1. Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–868. doi: 10.1038/nm.4358.
    1. Oduro-Donkor D, Turner MC, Farnaud S, Renshaw D, Kyrou I, Hanson P, et al. Modification of fecal microbiota as a mediator of effective weight loss and metabolic benefits following bariatric surgery. Expert Rev Endocrinol Metab. 2020;15(5):363–373. doi: 10.1080/17446651.2020.1801412.
    1. Pinheiro JA, Castro IRD, Ribeiro IB, Ferreira MVQ, Fireman PA, Madeiro MAD, et al. Repercussions of bariatric surgery on metabolic parameters: experience of 15-year follow-up in a hospital in Maceió, Brazil. ABCD Arq Bras Cir Dig. 2022;34(4):e1627–e1627. doi: 10.1590/0102-672020210002e1627.
    1. Raglan O, MacIntyre DA, Mitra A, Lee YS, Smith A, Assi N, et al. The association between obesity and weight loss after bariatric surgery on the vaginal microbiota. Microbiome. 2021;9(1):124–124. doi: 10.1186/s40168-021-01011-2.
    1. Sánchez-Alcoholado L, Gutiérrez-Repiso C, Gómez-Pérez AM, García-Fuentes E, Tinahones FJ, Moreno-Indias I. Gut microbiota adaptation after weight loss by Roux-en-Y gastric bypass or sleeve gastrectomy bariatric surgeries. Surg Obes Relat Dis. 2019;15(11):1888–1895. doi: 10.1016/j.soard.2019.08.551.
    1. Selber-Hnatiw S, Sultana T, Tse W, Abdollahi N, Abdullah S, Al Rahbani J, et al. Metabolic networks of the human gut microbiota. Microbiology (Reading) 2020;166(2):96–119. doi: 10.1099/mic.0.000853.
    1. Shao Y, Ding R, Xu B, Hua R, Shen Q, He K, et al. Alterations of gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in sprague-dawley rats. Obes Surg. 2017;27(2):295–302. doi: 10.1007/s11695-016-2297-7.
    1. Shen N, Caixàs A, Ahlers M, Patel K, Gao Z, Dutia R, et al. Longitudinal changes of microbiome composition and microbial metabolomics after surgical weight loss in individuals with obesity. Surg Obes Relat Dis. 2019;15(8):1367–1373. doi: 10.1016/j.soard.2019.05.038.
    1. Sroka-Oleksiak A, Młodzińska A, Bulanda M, Salamon D, Major P, Stanek M, et al. Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: a pilot study. J Clin Med. 2020;9(2):369–369. doi: 10.3390/jcm9020369.
    1. Talavera-Urquijo E, Beisani M, Balibrea JM, Alverdy JC. Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review. Surg Obes Relat Dis. 2020;16(9):1361–1369. doi: 10.1016/j.soard.2020.03.013.
    1. Wagner NRF, Zaparolli MR, Cruz MRR, Schieferdecker MEM, Campos ACL. Postoperative changes in intestinal microbiota and use of probiotics in Roux-en-Y gastric bypass and sleeve vertical gastrectomy: an integrative review. ABCD Arq Bras Cir Dig. 2018;31(4):e1400–e1400. doi: 10.1590/0102-672020180001e1400.
    1. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365–2370. doi: 10.1073/pnas.0812600106.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться